MoneyWorks4Me

Hester Biosciences exploring various opportunities to increase product portfolio

29 Oct 2018 Evaluate

Hester Biosciences is exploring various opportunities to increase the product portfolio and turnover. The company has reported net sales of Rs 80.80 crore in H1FY19 as compared to Rs 67.52 crore for the corresponding period of previous year, registering a growth of around 20%.

Hester Biosciences is engaged in the manufacturing of poultry vaccines.

Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1215.80
Cipla 1378.50
Lupin 2096.00
Zydus Lifesciences 1166.50
View more..